FERLENGHI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 951
NA - Nord America 791
AS - Asia 209
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.955
Nazione #
US - Stati Uniti d'America 782
IT - Italia 495
IE - Irlanda 143
CN - Cina 118
SE - Svezia 101
DE - Germania 58
AT - Austria 34
SG - Singapore 31
BE - Belgio 25
IN - India 24
FR - Francia 23
HK - Hong Kong 18
CZ - Repubblica Ceca 16
FI - Finlandia 15
GB - Regno Unito 11
UA - Ucraina 10
CA - Canada 8
JP - Giappone 6
TR - Turchia 6
HU - Ungheria 4
NL - Olanda 4
VN - Vietnam 4
BR - Brasile 3
RO - Romania 3
ES - Italia 2
LU - Lussemburgo 2
PL - Polonia 2
A1 - Anonimo 1
ID - Indonesia 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 1.955
Città #
Ann Arbor 209
Chandler 188
Dublin 137
Parma 112
Ashburn 51
Shanghai 39
Bologna 31
Vienna 28
Los Angeles 24
New York 22
Beijing 20
Princeton 20
Bremen 19
Modena 18
Boardman 16
Brescia 16
Milan 16
Wilmington 15
Brussels 14
Helsinki 14
Hong Kong 14
Singapore 13
Brno 11
Prata Di Pordenone 11
Des Moines 9
Vigevano 9
Guangzhou 8
Jinan 8
Leuven 8
Montegaldella 7
Nanjing 7
Pune 7
Shenyang 7
Dearborn 6
Follonica 6
Fremont 6
Hyderabad 6
Neviano degli Arduini 6
Palermo 6
Segrate 6
Soliera 6
Collecchio 5
Fairfield 5
San Mateo 5
Verona 5
Ankara 4
Ardea 4
Dong Ket 4
Ferrara 4
Reggio Emilia 4
Rimini 4
Sant'ilario D'enza 4
Tokyo 4
Trento 4
Braunschweig 3
Chiari 3
Diegem 3
Düsseldorf 3
Erba 3
Grafing 3
Jiaxing 3
Magdeburg 3
Montreal 3
Piemonte 3
Prato 3
Redwood City 3
Reggio Nell'emilia 3
Rome 3
Seattle 3
São Paulo 3
Bergamo 2
Caorso 2
Carpi 2
Central 2
Changsha 2
Charleston 2
Concordia sulla Secchia 2
Frontone 2
Grignasco 2
Hangzhou 2
Houston 2
Izmir 2
Kansas City 2
Lübeck 2
Maranello 2
Mountain View 2
Naples 2
Newcastle upon Tyne 2
Osimo 2
Paris 2
Pavia 2
Quattro Castella 2
Rho 2
Salerno 2
Salsomaggiore Terme 2
Saviano 2
Sendai 2
Suzzara 2
Toronto 2
Trezzano Sul Naviglio 2
Totale 1.340
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 199
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 149
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 131
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 122
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 111
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 103
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 101
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice 98
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 98
Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats 92
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine 71
(2S,4R)-4-fluoroglutamine is converted into (2S,4R)-4-fluoroglutamate by glutaminase activity and may be exploited as a PET tracer in glutamine-addicted cancers 71
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 69
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids 68
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability 61
Palladium Catalyst Recycling for Heck-Cassar-Sonogashira Cross-Coupling Reactions in Green Solvent/Base Blend 61
Social stress-induced depressive-like symptoms and changes in gut microbial and lipidomic profiles are prevented by pharmacological inhibition of FAAH activity in male rats 59
Steps towards sustainable solid phase peptide synthesis: use and recovery ofN-octyl pyrrolidone 56
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 55
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity in Vivo 51
Role of sphingolipid metabolism in osimertinib-resistance in EGFR-mutated NSCLC models 49
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 38
The GABAB receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 37
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 30
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 23
Enhancement of peripheral fatty acyl ethanolamide signaling prevents stress‑induced social avoidance and anxiety‑like behaviors in male rats 17
Totale 2.020
Categoria #
all - tutte 6.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020248 11 6 6 10 9 24 38 17 34 54 23 16
2020/2021337 11 14 32 40 29 34 50 22 29 27 18 31
2021/2022285 8 18 16 49 22 5 38 24 30 20 11 44
2022/2023732 57 76 54 75 70 88 12 58 175 29 29 9
2023/2024396 21 15 19 5 21 55 38 30 26 40 67 59
Totale 2.020